Your browser doesn't support javascript.
loading
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial.
Julg, Boris; Stephenson, Kathryn E; Wagh, Kshitij; Tan, Sabrina C; Zash, Rebecca; Walsh, Stephen; Ansel, Jessica; Kanjilal, Diane; Nkolola, Joseph; Walker-Sperling, Victoria E K; Ophel, Jasper; Yanosick, Katherine; Borducchi, Erica N; Maxfield, Lori; Abbink, Peter; Peter, Lauren; Yates, Nicole L; Wesley, Martina S; Hassell, Tom; Gelderblom, Huub C; deCamp, Allen; Mayer, Bryan T; Sato, Alicia; Gerber, Monica W; Giorgi, Elena E; Gama, Lucio; Koup, Richard A; Mascola, John R; Monczor, Ana; Lupo, Sofia; Rolle, Charlotte-Paige; Arduino, Roberto; DeJesus, Edwin; Tomaras, Georgia D; Seaman, Michael S; Korber, Bette; Barouch, Dan H.
Afiliación
  • Julg B; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
  • Stephenson KE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Wagh K; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
  • Tan SC; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Zash R; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.
  • Walsh S; New Mexico Consortium, Los Alamos, NM, USA.
  • Ansel J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Kanjilal D; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Nkolola J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Walker-Sperling VEK; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Ophel J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Yanosick K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Borducchi EN; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Maxfield L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Abbink P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Peter L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Yates NL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Wesley MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Hassell T; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Gelderblom HC; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
  • deCamp A; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
  • Mayer BT; International AIDS Vaccine Initiative, New York, NY, USA.
  • Sato A; International AIDS Vaccine Initiative, New York, NY, USA.
  • Gerber MW; Icosavax Inc., Seattle, WA, USA.
  • Giorgi EE; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Gama L; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Koup RA; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Mascola JR; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Monczor A; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.
  • Lupo S; New Mexico Consortium, Los Alamos, NM, USA.
  • Rolle CP; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA.
  • Arduino R; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA.
  • DeJesus E; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA.
  • Tomaras GD; Houston AIDS Research Team, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Seaman MS; Houston AIDS Research Team, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Korber B; Orlando Immunology Center, Orlando, FL, USA.
  • Barouch DH; Houston AIDS Research Team, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, USA.
Nat Med ; 28(6): 1288-1296, 2022 06.
Article en En | MEDLINE | ID: mdl-35551291
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Seropositividad para VIH Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Seropositividad para VIH Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos